Summit Securities Group’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-1,725
Closed -$1K 956
2023
Q1
$1K Buy
+1,725
New +$1K ﹤0.01% 617